Innovative Therapeutic Areas

Driving the next chapter of neuroscience

At Teva, we focus on addressing some of the most complex and urgent challenges in neuroscience today.

Our focus areas in neuroscience

More than 3 billion people worldwide are living with a neurological condition, and for too many, stability, timely intervention, and continuity of care remain out of reach. Teva is translating breakthroughs into medicines, advancing innovative solutions across severe mental illness, movement disorders, migraine, and neurodegenerative disorders with scale, speed and precision. Because we believe earlier intervention matters. We believe outcomes matter. And we believe the measure of innovation is not in the molecule alone – it is the fuller life, hope and future it makes possible. 

Severe mental illness

Teva’s neuroscience research studies biological and neurological processes behind schizophrenia and related disorders.

Explore mental illness

Movement disorders

Exploring the science behind movement disorders, including HD chorea, tardive dyskinesia.

Explore Movement disorders

Migraine

Exploring the neurological processes behind migraine, a complex condition with recurrent episodes and sensory symptoms.

Explore Migraine

Teva's Heritage and Ambitions in Neuroscience

Why neuroscience – and why now

The neuroscience field is in a renaissance, with sharper disease biology, new targets beyond classic paradigms, and better tools to measure effect. With one in three people living with a neurological condition the need is vast, durable, and still largely unmet. For many, stability, timely intervention, and continuity of care remain out of reach.

In conversation with...Dr. Dieter Schulterwolter VP,  head of Neuroscience, Global Medical Affairs Teva's Heritage and Ambitions in Neuroscience

Interview with Dieter Schultewolter: 2-minute external video

What is your work in the field of neuroscience and at Teva? Dieter: I've been working in neuroscience now for 30 years as a medical doctor and as a professional in medical affairs. There's one thing I really learned about neurological conditions. It destroys people's life, the lives as they have known it comes to an end so I'm driven very much by bridging the gap between clinical research and medical practice. After all, I think it’s the coolest thing I could ever do to help somebody else, to give somebody hope. Does Teva have a strong heritage in neuroscience? Dieter: Teva is not a newcomer to neuroscience. We have a very strong footprint in neuroscience, and it started nearly 30 years ago in multiple sclerosis. So we now have medications in migraine and headache, movement disorders but also lately in schizophrenia and let’s not forget, we also have a very broad generics portfolio in neuroscience, that makes medication accessible all over the globe to people who need it. Is Teva also investigating new technologies? Dieter: We have to use the modern technology. We have to combine it with the tried and tested in order to speed up the development of medications. Patients can't wait ten plus years for a new medication to come along so we are using AI for different purposes to enhance diagnosis, but also to speed up the clinical development program. Has Teva prioritized neuroscience due to its high unmet patient need? Dieter: Neuroscience has got a very high unmet medical need. There's great suffering, to illustrate that, one third of the global population suffers from a condition which is under the umbrella of neuroscience. That's not necessary and we can do something about it and Teva actually does do something about it.

Dr. Dieter Schultewolter VP,  head of Neuroscience, Global Medical Affairs.

NPS-ALL-NP-01757 MARCH 2026

Neuroscience

Teva's Heritage and Ambitions in Neuroscience

Discover Our Scientific Expertise

Teva, Leading the Charge

Neurological conditions take so much. With our decades of commitment to neuroscience, Teva is working to give something back.

Learn more
Neuro Psych Bytes

Teva’s HCP Information Hub

A scientific platform for healthcare professionals offering insights on migraine, multiple sclerosis, tardive dyskinesia and schizophrenia.

HCP resources
Nurse with an old lady smiling

Explore Teva’s Solutions

We also offer practical resources for disease education and support in our Solutions section.

Discover more

Additional resources

We see the person, not the diagnosis

In neuroscience, the barriers are both scientific and societal. Delayed diagnosis, persistent stigma, and treatment models that do not account for the clinical and human complexities of neurological conditions, continue to stand in the way of stability and opportunity. We believe that when treatment is designed around a patient's life, outcomes improve and the science advances. For us, continuity of care is not optional – it is the difference between stability and relapse, independence and crisis. 

Tardive Dyskinesia Disease Infographic

What to know about TD Infographic

Huntington’s disease (HD) chorea Infographic

What to know about HD Infographic

The burden of schizophrenia

This section highlights Teva’s European White Paper "What Lies Beneath: Uncovering the Hidden Drivers and Impact of Stigma in Schizophrenia", which examines factors contributing to stigma and discusses insights relevant to the scientific and policy communities.

Read the Full Report

Patient insights

Our Life Effects hub shares real-life experiences from people living with conditions such as migraine, Huntington’s disease, schizophrenia, and tardive dyskinesia.

Life Effects stories

FAQs: Innovative therapeutic areas

What does "innovative therapeutic areas" mean?

Toggle Expand/ Collapse

“Innovative therapeutic areas” refers to fields of medical science where researchers are working to expand understanding of complex health conditions. These areas often involve emerging knowledge, new scientific methods, or fresh approaches to studying diseases that remain difficult to understand or manage.

What types of conditions are included in neuroscience research?

Toggle Expand/ Collapse

Neuroscience research looks at conditions that affect the brain, spinal cord, and nervous system. This includes movement disorders that impact coordination and muscle control, migraines that cause recurring headaches and sensory symptoms, and serious mental health conditions such as schizophrenia.

These disorders may significantly impact thinking, behavior, and daily activities. A deeper understanding of these conditions helps researchers explore new ways to support people who live with them.

What are movement disorders?

Toggle Expand/ Collapse

Movement disorders are conditions that affect how a person moves. They can cause problems like shaking, stiff muscles, slow movements, trouble with balance, or sudden movements that are hard to control.

Some movement disorders may progress over time, while others stay stable. Since movement is important for daily activities, these disorders can impact a person's independence, mobility, and overall quality of life. This makes them a key area for ongoing research.

What mental health conditions are part of neuroscience research?

Toggle Expand/ Collapse

Neuroscience research includes several long term and complex mental health conditions, such as schizophrenia, schizoaffective disorder, and bipolar disorder. These conditions involve disruptions in mood, thinking, perception, or behavior, and can vary greatly in how they appear from person to person.

Researchers study biological, genetic, and environmental factors to better understand how these conditions develop and vary across individuals.

Where does Teva conduct its neuroscience research?

Teva’s neuroscience research is supported by multidisciplinary teams across global R&D hubs in the United States, Israel, India, Croatia, the United Kingdom, and Australia.

How is Teva’s neuroscience research supported globally?

Approximately 3,700 employees support Teva’s neuroscience efforts worldwide, collaborating across locations to advance scientific understanding of neurological and psychiatric conditions.

How does research in therapeutic areas help patients?

Toggle Expand/ Collapse

Research in therapeutic areas helps build scientific knowledge about how diseases work and evolve. By looking at biological processes and how conditions develop, researchers can identify gaps in knowledge that need more exploration. This information can influence future research directions and other scientific efforts. 

Why is collaboration important in medical research?

Toggle Expand/ Collapse

Collaboration is vital in medical research because complex health conditions often require expertise that looks at different biological, environmental, and social factors. When researchers, doctors, data experts, and scientific teams work together, they can share insights that may not come from just one discipline.

Working together helps scientific communities explore new ideas, compare approaches, and strengthen the overall research process. By combining their knowledge, research communities can address challenges more effectively and in a coordinated way.